TGA regulation, price pressure and compliance issues are reducing access to medicines, and reducing industry confidence, a PwC report claims. Challenges and Change—a report on the Australian pharmaceutical industry, released today, canvassed the views of representatives from 23 organisations including industry bodies and pharmaceutical companies. More than 50% of companies surveyed had annual turnovers in
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.